<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2457">
 <bold>Conclusions:</bold> Thus, in abdominal sepsis patients with NP and ARDS new molecular biomarkers can be used for ARDS diagnosis (SPD) and prognostification of outcomes (SPA).
</p>
